Laurence Reilly
Director/Board Member en IMMUPHARMA PLC .
Perfil
Laurence Reilly is currently a Senior Independent Non-Executive Director at ImmuPharma Plc and a Vice President-Research & Investments at Royalty Pharma Plc.
He previously worked as the Chief Scientific Officer & Vice President at Avillion LLP and as the Chief Medical Officer at Cellectar Biosciences, Inc. Reilly holds a doctorate degree from The University of Liverpool and a graduate degree from De Montfort University.
Cargos activos de Laurence Reilly
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUPHARMA PLC | Director/Board Member | 11/08/2023 |
| ROYALTY PHARMA PLC | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Laurence Reilly.
| Empresas | Cargo | Fin |
|---|---|---|
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
| CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Laurence Reilly.
| The University of Liverpool | Doctorate Degree |
| De Montfort University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| IMMUPHARMA PLC | Health Technology |
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Laurence Reilly
